Evidence map›Paper›PMID 21625610›Full record

ArticleFrontiers in neuroscience2011

Computational detection of alternative exon usage.

Ted G Laderas, Nicole A R Walter, Michael Mooney, Kristina Vartanian, Priscila Darakjian, Kari Buck, Christina A Harrington, John Belknap, Robert Hitzemann, Shannon K McWeeney

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Introduction to sequencing the brain transcriptome.International review of neurobiology · 2014
    Review
  4. Genetics of gene expression in CNS.International review of neurobiology · 2014
    Review
  5. Differential splicing across immune system lineages.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  6. Genes, behavior and next-generation RNA sequencing.Genes, brain, and behavior · 2013
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ted G LaderasOregon Clinical Research and Translational Institute, Oregon Health and Science University Portland, OR, USA.
Nicole A R Walter
Michael Mooney
Kristina Vartanian
Priscila Darakjian
Kari Buck
Christina A Harrington
John Belknap
Robert Hitzemann
Shannon K McWeeney
Oregon Health & Science University · USPortland VA Medical Center · USTranslational Research Institute · AU

Funding

OREGON CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024140 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2006 to 2011
$61.1M
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Translational measures of risk for excessive alcohol consumptionP60AA010760 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Suzanne S. Fei · 2006 to 2026
$34.5M
TRAINING PROGRAM IN HEALTH INFORMATICST15LM007088 · NLM · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAM R HERSH, Vishnu Mohan · 1992 to 2026
$23.4M
THERMAL AND METABOLIC DYSFUNCTION DURING WITHDRAWALP50AA010760 · NIAAA · OREGON HEALTH AND SCIENCE UNIVERSITY · PI CRABBE, JOHN C. · 1996 to 2005
$10.7M
Neurocircuitry Mapping and Genotyping CoreU01AA013484 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI HITZEMANN, ROBERT J. · 2001 to 2021
$6.2M
Mapping the Genes for Ethanol-Related PhenotypesR01AA011034 · NIAAA · STATE UNIVERSITY NEW YORK STONY BROOK · PI HITZEMANN, ROBERT J. · 1996 to 2014
$5.1M
GENETIC VULNERABILITY TO DRUGS OF ABUSER01DA005228 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI BUCK, KARI J · 1989 to 2015
$4.6M
The Role of Mpdz in Ethanol Withdrawal and Genetically Correlated BehaviorsR01AA011114 · NIAAA · OREGON HEALTH & SCIENCE UNIVERSITY · PI BUCK, KARI J · 2000 to 2020
$4.3M
MAPPING THE GENES FOR NEUROLEPTIC RESPONSER01MH051372 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI HITZEMANN, ROBERT J. · 1995 to 2014
$4.0M
ETHANOL WITHDRAWAL QTLS AND CANDIDATE GENESR29AA011114 · NIAAA · OREGON HEALTH AND SCIENCE UNIVERSITY · PI BUCK, KARI J · 1997 to 1999
–
NCI NIH HHS P30 CA069533NCRR NIH HHS UL1 RR024140NIAAA NIH HHS P50 AA010760NIAAA NIH HHS P60 AA010760NIAAA NIH HHS R01 AA011034NIAAA NIH HHS R01 AA011114NIAAA NIH HHS R29 AA011114NIAAA NIH HHS U01 AA013484NIDA NIH HHS R01 DA005228NIMH NIH HHS R01 MH051372NLM NIH HHS T15 LM007088
6 · The paper itself

Abstract

backgroundWith the advent of the GeneChip Exon Arrays, it is now possible to extract "exon-level" expression estimates, allowing for detection of alternative splicing events, one of the primary mechanisms of transcript diversity. In the context of (1) a complex trait use case and (2) a human cerebellum vs. heart comparison on previously validated data, we present a transcript-based statistical model and validation framework to allow detection of alternative exon usage (AEU) between different groups. To illustrate the approach, we detect and confirm differences in exon usage in the two of the most widely studied mouse genetic models (the C57BL/6J and DBA/2J inbred strains) and in a human dataset.

resultsWe developed a computational framework that consists of probe level annotation mapping and statistical modeling to detect putative AEU events, as well as visualization and alignment with known splice events. We show a dramatic improvement (∼25 fold) in the ability to detect these events using the appropriate annotation and statistical model which is actually specified at the transcript level, as compared with the transcript cluster/gene-level annotation used on the array. An additional component of this workflow is a probe index that allows ranking AEU candidates for validation and can aid in identification of false positives due to single nucleotide polymorphisms. DISCUSSION: Our work highlights the importance of concordance between the functional unit interrogated (e.g., gene, transcripts) and the entity (e.g., exon, probeset) within the statistical model. The framework we present is broadly applicable to other platforms (including RNAseq).

Indexed as

alternative splicingexon array

Identifiers

PMID21625610
PMCPMC3097375
OpenAlexW1974955933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.